Add Company
Join Now

Yacine Salhi Email

VP Biostatistics, Programming, Modeling & Simulation . Sage Therapeutics

Cambridge, MA

Location

How to contact Yacine Salhi

Join and see Yacine's contact info for free!

Email

Current Roles

Sage Therapeutics

Employees:
768
Revenue:
$97.7M
About
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage's lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Sage Therapeutics Address
215 First Street
Cambridge, MA
United States

Past Companies

Sage TherapeuticsVice President of Biostatistics, Programming, Modeling & Simulation
Ichnos SciencesVice President, Global Head of Biometrics
Glenmark PharmaceuticalsExecutive Director, Global Head of Biometrics
www.growjo.com

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.